Stroke, Vol 23, 69-74, Copyright © 1992 by American Heart Association
LP Yao, J Bandres, EM Nemoto, JR Boston, JM Darby and H Yonas
BACKGROUND AND PURPOSE: Despite the documented diagnostic value of local
cerebral blood flow maps by xenon-enhanced computed tomography, reports of
cerebral blood flow activation by inhaled 33% Xe raised concerns about the
method's safety and accuracy. We evaluated the effect of 33% Xe inhalation
on cerebral blood flow and cerebral metabolic rates for oxygen and glucose
in four awake and six fentanyl- anesthetized rhesus monkeys. METHODS:
Platinum microelectrodes and catheters in the torcular Herophili were used
to measure cerebral blood flow by hydrogen clearance, and oxygen and
glucose concentrations. Cerebral variables were measured after 5 and 35
minutes of exposure to room air followed randomly by 67% O2 in 33% N2 or
Xe. Five- and 35- minute measurements were combined because the duration of
exposure had no effect. RESULTS: In awake monkeys, 33% Xe compared with 33%
N2 reduced (p less than 0.05) cerebral blood flow from 75 +/- 12 to 66 +/-
9 (mean +/- SD) ml.100 g-1.min-1 and oxygen consumption from 6.1 +/- 0.7 to
5.1 +/- 0.6 ml.100 g-1.min-1. In fentanyl-anesthetized monkeys, cerebral
variables during 33% N2 versus 33% Xe were cerebral blood flow, 84 +/- 26
versus 79 +/- 23 ml.100 g-1.min-1; oxygen consumption, 5.0 +/- 0.7 versus
4.9 +/- 0.5 ml.100 g-1.min-1; and glucose consumption, 8.4 +/- 1.9 versus
7.9 +/- 2.0 mg.100 g-1.min-1. CONCLUSIONS: In awake monkeys, 33% Xe reduced
rather than activated cerebral blood flow and oxygen consumption by 12% and
16%, respectively; it had no effect in fentanyl-anesthetized monkeys.
ARTICLES
Effect of 33% xenon inhalation on whole-brain blood flow and metabolism in awake and fentanyl-anesthetized monkeys
Department of Anesthesiology, University of Pittsburgh, School of Medicine, Pa 15261.
This article has been cited by other articles:
![]() |
R. M. Laitio, J. W. Langsjo, S. Aalto, K. K. Kaisti, E. Salmi, A. Maksimow, R. Aantaa, V. Oikonen, T. Viljanen, R. Parkkola, et al. The Effects of Xenon Anesthesia on the Relationship Between Cerebral Glucose Metabolism and Blood Flow in Healthy Subjects: A Positron Emission Tomography Study Anesth. Analg., February 1, 2009; 108(2): 593 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rex, P. T. Meyer, J.-H. Baumert, R. Rossaint, M. Fries, U. Bull, and W. M. Schaefer Positron emission tomography study of regional cerebral blood flow and flow-metabolism coupling during general anaesthesia with xenon in humans Br. J. Anaesth., May 1, 2008; 100(5): 667 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. David, B. Haelewyn, C. Rouillon, M. Lecoq, L. Chazalviel, G. Apiou, J.-J. Risso, M. Lemaire, and J. H. Abraini Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia FASEB J, April 1, 2008; 22(4): 1275 - 1286. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |